Ligand Pharmaceuticals Incorporated Human Resources Contracts & Agreements
13 Contracts & Agreements
- Bonus & Incentive Agreements (3 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (1)
- Employment Agreements (1)
- Separation Agreements (4)
- Severance Agreements (3)
- Form of Change in Control Severance Agreement (Filed With SEC on May 8, 2023)
- Severance Agreement, effective December 5, 2022, by and between Ligand Pharmaceuticals Incorporated and Todd C. Davis (Filed With SEC on February 28, 2023)
- Separation Agreement , effective December 12, 2022, by and between Ligand Pharmaceuticals Incorporated and John Higgins (Filed With SEC on February 28, 2023)
- Amended and Restated Severance Plan, effective November 1, 2022 (Filed With SEC on February 28, 2023)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the Companys 2022 Employment Inducement Plan (Filed With SEC on August 9, 2022)
- 2022 Employment Inducement Plan (Filed With SEC on August 9, 2022)
- 2002 Stock Incentive Plan (as amended and restated effective December 15, 2020) (Filed With SEC on February 24, 2021)
- SEPARATION AGREEMENT (Filed With SEC on August 8, 2012)
- LIGAND PHARMACEUTICALS INCORPORATED DIRECTOR COMPENSATION AND STOCKOWNERSHIP POLICY (Amended and Restated Effective June 1, 2011) I. DIRECTOR COMPENSATION (Filed With SEC on August 8, 2011)
- SEPARATION AGREEMENT (Filed With SEC on May 11, 2009)
- LIGAND PHARMACEUTICALS INCORPORATED AMENDED AND RESTATED SEVERANCE PLAN (AND SUMMARY PLAN DESCRIPTION) (Filed With SEC on December 24, 2008)
- LIGAND PHARMACEUTICALS INCORPORATED 2002 STOCK INCENTIVE PLAN (Filed With SEC on March 5, 2008)
- SEPARATION AGREEMENT (Filed With SEC on August 4, 2006)
